These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
44. Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes. Batchelor LK; Păunescu E; Soudani M; Scopelliti R; Dyson PJ Inorg Chem; 2017 Aug; 56(16):9617-9633. PubMed ID: 28758743 [TBL] [Abstract][Full Text] [Related]
45. α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes. Biancalana L; Batchelor LK; Funaioli T; Zacchini S; Bortoluzzi M; Pampaloni G; Dyson PJ; Marchetti F Inorg Chem; 2018 Jun; 57(11):6669-6685. PubMed ID: 29790340 [TBL] [Abstract][Full Text] [Related]
46. Metal complexes as DNA intercalators. Liu HK; Sadler PJ Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672 [TBL] [Abstract][Full Text] [Related]
47. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms. Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367 [TBL] [Abstract][Full Text] [Related]
49. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand. Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818 [TBL] [Abstract][Full Text] [Related]
50. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties. Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936 [TBL] [Abstract][Full Text] [Related]
51. Ruthenium(II) piano stool coordination compounds with aminomethylphosphanes: Synthesis, characterisation and preliminary biological study in vitro. Płotek M; Starosta R; Komarnicka UK; Skórska-Stania A; Kołoczek P; Kyzioł A J Inorg Biochem; 2017 May; 170():178-187. PubMed ID: 28259056 [TBL] [Abstract][Full Text] [Related]
52. Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. He L; Liao SY; Tan CP; Ye RR; Xu YW; Zhao M; Ji LN; Mao ZW Chemistry; 2013 Sep; 19(36):12152-60. PubMed ID: 23878093 [TBL] [Abstract][Full Text] [Related]
53. Similarities and differences in d Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765 [TBL] [Abstract][Full Text] [Related]
54. New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application. Fandzloch M; Jędrzejewski T; Dobrzańska L; Esteban-Parra GM; Wiśniewska J; Paneth A; Paneth P; Sitkowski J Dalton Trans; 2021 Apr; 50(16):5557-5573. PubMed ID: 33908935 [TBL] [Abstract][Full Text] [Related]
55. Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands. Kong Y; Chen F; Su Z; Qian Y; Wang FX; Wang X; Zhao J; Mao ZW; Liu HK J Inorg Biochem; 2018 May; 182():194-199. PubMed ID: 29501980 [TBL] [Abstract][Full Text] [Related]
56. Anticancer and antibacterial potential of robust Ruthenium(II) arene complexes regulated by choice of α-diimine and halide ligands. Zanda E; Busto N; Biancalana L; Zacchini S; Biver T; Garcia B; Marchetti F Chem Biol Interact; 2021 Aug; 344():109522. PubMed ID: 34029541 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes. Maroto-Díaz M; Elie BT; Gómez-Sal P; Pérez-Serrano J; Gómez R; Contel M; Javier de la Mata F Dalton Trans; 2016 Apr; 45(16):7049-66. PubMed ID: 26990859 [TBL] [Abstract][Full Text] [Related]
58. Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity. Rajendiran V; Murali M; Suresh E; Sinha S; Somasundaram K; Palaniandavar M Dalton Trans; 2008 Jan; (1):148-63. PubMed ID: 18399241 [TBL] [Abstract][Full Text] [Related]
59. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action. Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123 [TBL] [Abstract][Full Text] [Related]
60. Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Mohamed Subarkhan MK; Ren L; Xie B; Chen C; Wang Y; Wang H Eur J Med Chem; 2019 Oct; 179():246-256. PubMed ID: 31255925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]